Involuntary movements
52 results
1 - 52Involuntary movements
Botulinum toxin type A versus anticholinergics for cervical dystonia: Cochrane systematic review
Essential tremor
Amantadine for dyskinesia in Parkinson's disease: Cochrane systematic review
Botulinum toxin type A therapy for hemifacial spasm Edited (no change to conclusions)
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia: Cochrane systematic review
Aripiprazole for autism spectrum disorders (ASD) New search for studies and content updated (no change to conclusions)
Antipsychotics for acute and chronic pain
Epilepsy in children
Lisuride for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
Monoamine oxidase B inhibitors for early Parkinson's disease: Cochrane systematic review
Physical therapy for Bell's palsy (idiopathic facial paralysis): Cochrane systematic review
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease New
Clinical assessment of memory impairment
Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
Lisuride versus bromocriptine for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
Ropinirole versus bromocriptine for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease New
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
Pramipexole for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
Cabergoline for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia: Cochrane systematic review
Tremor
Ropinirole for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
Fluphenazine (oral) versus placebo for schizophrenia Edited (no change to conclusions)
Pergolide for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
Trihexyphenidyl for dystonia in cerebral palsy: Cochrane systematic review
Vitamin E for antipsychotic‐induced tardive dyskinesia Edited (no change to conclusions)
Antipsychotics for acute and chronic pain in adults: Cochrane systematic review
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia New search for studies and content updated (conclusions changed)
Withdrawal versus continuation of long‐term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia New search for studies and content updated (no change to conclusions)
Schizophrenia
Rehabilitation of patients with spinal cord injury, and problems associated with such injury